The aim of this study is to identify the frequencies of major polymorphisms of candidate genes, TPMT, NUDT15, ITPA, and APEX1, and evaluate whether these variations and combination of them could predict 6-MP intolerance and toxicity during maintenance therapy in pediatric ALL patients. This evidence concerns the gene TPMT and acute lymphoblastic leukemia.